🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 1 día
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/10/1996 | 52,40 | 52,40 | 51,00 | 51,47 | -0,90% | 2,68% | 40.022 |
| 15/10/1996 | 51,47 | 52,40 | 50,53 | 51,93 | +0,00% | 3,64% | 48.197 |
| 14/10/1996 | 52,40 | 52,87 | 51,47 | 51,93 | -1,77% | 2,68% | 26.262 |
| 11/10/1996 | 51,47 | 52,87 | 50,53 | 52,87 | +4,63% | 4,55% | 16.217 |
| 10/10/1996 | 51,47 | 51,47 | 50,53 | 50,53 | +0,00% | 1,82% | 4.382 |
| 09/10/1996 | 50,06 | 51,47 | 50,06 | 50,53 | +0,00% | 2,80% | 9.191 |
| 08/10/1996 | 52,40 | 52,40 | 50,06 | 50,53 | -2,70% | 4,46% | 24.820 |
| 07/10/1996 | 52,87 | 52,87 | 51,47 | 51,93 | -0,89% | 2,65% | 51.269 |
| 04/10/1996 | 50,53 | 52,87 | 50,53 | 52,40 | +3,70% | 4,63% | 77.345 |
| 03/10/1996 | 50,53 | 51,93 | 50,53 | 50,53 | -2,70% | 2,78% | 6.412 |
| 02/10/1996 | 51,47 | 52,40 | 50,53 | 51,93 | -0,89% | 3,64% | 29.923 |
| 01/10/1996 | 52,40 | 52,40 | 51,00 | 52,40 | +2,75% | 2,68% | 17.019 |
| 30/09/1996 | 52,87 | 52,87 | 51,00 | 51,00 | -3,54% | 3,54% | 42.773 |
| 27/09/1996 | 51,47 | 52,87 | 51,47 | 52,87 | +0,00% | 2,73% | 5.049 |
| 26/09/1996 | 53,34 | 53,34 | 50,53 | 52,87 | +0,89% | 5,26% | 31.071 |
| 25/09/1996 | 54,27 | 54,27 | 52,40 | 52,40 | -5,08% | 3,45% | 74.700 |
| 24/09/1996 | 54,27 | 56,14 | 53,34 | 55,21 | +2,61% | 5,17% | 30.350 |
| 23/09/1996 | 54,74 | 54,74 | 53,34 | 53,81 | -0,86% | 2,56% | 24.285 |
| 20/09/1996 | 56,14 | 58,02 | 54,27 | 54,27 | -3,33% | 6,67% | 24.713 |
| 19/09/1996 | 56,61 | 59,89 | 56,14 | 56,14 | +0,00% | 6,61% | 44.777 |
| 18/09/1996 | 54,27 | 56,14 | 54,27 | 56,14 | +0,00% | 3,45% | 10.660 |
| 17/09/1996 | 55,21 | 56,14 | 54,27 | 56,14 | +3,45% | 3,39% | 18.488 |
| 16/09/1996 | 55,21 | 57,08 | 54,27 | 54,27 | -2,52% | 5,08% | 32.995 |
| 13/09/1996 | 58,95 | 58,95 | 55,21 | 55,68 | -4,80% | 6,35% | 100.775 |
| 12/09/1996 | 50,53 | 60,36 | 49,13 | 58,48 | +19,05% | 22,22% | 395.807 |
| 11/09/1996 | 48,19 | 49,13 | 48,19 | 49,13 | +0,00% | 1,94% | 8.042 |
| 10/09/1996 | 47,26 | 50,06 | 47,26 | 49,13 | +2,94% | 5,94% | 31.953 |
| 09/09/1996 | 45,85 | 48,19 | 45,85 | 47,72 | +4,08% | 5,10% | 9.538 |
| 06/09/1996 | 45,38 | 46,79 | 44,92 | 45,85 | -2,00% | 4,12% | 36.922 |
| 05/09/1996 | 43,98 | 46,79 | 43,98 | 46,79 | +3,09% | 6,38% | 20.545 |